U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H14N5O8P
Molecular Weight 363.2206
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5'-GUANYLIC ACID

SMILES

NC1=NC2=C(N=CN2[C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C(=O)N1

InChI

InChIKey=RQFCJASXJCIDSX-UUOKFMHZSA-N
InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H14N5O8P
Molecular Weight 363.2206
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Nitric oxide as modulator of neuronal function.
2001-05
Modulation of nitrergic relaxant responses by peptides in the mouse gastric fundus.
2001-04-02
Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis.
2001-04
Opposing actions of nitric oxide on synaptic inputs of identified interneurones in the central nervous system of the crayfish.
2001-04
Crystal structure of unligated guanylate kinase from yeast reveals GMP-induced conformational changes.
2001-03-16
Guanylate cyclase in Dictyostelium discoideum with the topology of mammalian adenylate cyclase.
2001-03-15
Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(mREN2)27 rats.
2001-03-09
NO-independent regulatory site on soluble guanylate cyclase.
2001-03-08
Neural network partitioning by NO and cGMP.
2001-03-01
Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter.
2001-03
Adenovirus-mediated transfer of the atrial natriuretic peptide gene in rat pulmonary vascular smooth muscle cells leads to apoptosis.
2001-03
Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
2001-03
Differential expression of functional guanylyl cyclases in melanocytes: absence of nitric-oxide-sensitive isoform in metastatic cells.
2001-03
NO/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules.
2001-03
Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium.
2001-03
Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.
2001-03
Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
2001-03
Plasma from preeclamptic women stimulates decidual endothelial cell growth and prostacyclin but not nitric oxide production: close correlation of prostacyclin and thromboxane production.
2001-02-27
Immunohistochemical localization of nitric oxide synthase and soluble guanylyl cyclase in the ventral cochlear nucleus of the rat.
2001-02-26
G protein-mediated inhibitory effect of a nitric oxide donor on the L-type Ca2+ current in rat ventricular myocytes.
2001-02-15
Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheep.
2001-02
Distribution of genetic variation among chromosomal forms of Anopheles gambiae s.s: introgressive hybridization, adaptive inversions, or recent reproductive isolation?
2001-02
Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control.
2001-02
[Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
2001-02
NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase.
2001-02
Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes.
2001-02
Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
2001-02
Effects of short chain fatty acids on colonic Na+ absorption and enzyme activity.
2001-02
Natriuretic peptide receptors in the central vasculature of the toad, Bufo marinus.
2001-02
Soluble substances released from postischemic reperfused rat hearts reduce calcium transient and contractility by blocking the L-type calcium channel.
2001-02
Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction.
2001-02
Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells.
2001-02
Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway.
2001-02
Effect of E. coli heat-stable enterotoxin on colonic transport in guanylyl cyclase C receptor-deficient mice.
2001-02
Utilization of brewer's yeast cells for the production of food-grade yeast extract. Part 1: Effects of different enzymatic treatments on solid and protein recovery and flavor characteristics.
2001-02
Paracrine neuroprotective effect of nitric oxide in the developing retina.
2001-02
Mechanisms involved in SNP-induced relaxation and [Ca+]i reduction in piglet pulmonary and systemic arteries.
2001-02
Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.
2001-02
Use of nucleotides in weanling rats with diarrhea induced by a lactose overload: effect on the evolution of diarrhea and weight and on the histopathology of intestine, liver and spleen.
2001-02
An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
2001-02
Roles for nitric oxide and arachidonic acid in the induction of heterosynaptic cerebellar LTD.
2001-01-22
Possibility of age regulation of the natriuretic peptide C-receptor in human platelets.
2001-01
The effects of vasopressin in isolated rat hearts.
2001-01
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes.
2001-01
Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.
2001-01
alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock.
2001-01
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin.
2001-01
Methylene blue as a successful treatment alternative for pharmacologically induced priapism.
2001-01
The guanylyl cyclase family at Y2K.
2001
C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:12:27 GMT 2025
Edited
by admin
on Mon Mar 31 21:12:27 GMT 2025
Record UNII
16597955EP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
5'-GUANYLIC ACID
MI  
Systematic Name English
E 626
Preferred Name English
GUANOSINE 5'-(DIHYDROGEN PHOSPHATE)
Systematic Name English
GMP
Common Name English
GUANOSINE 5'-PHOSPHATE
Systematic Name English
INS NO.626
Code English
5'-GUANYLIC ACID [MI]
Common Name English
GUANOSINE 5'-MONOPHOSPHORIC ACID
Common Name English
GUANOSINE MONOPHOSPHATE
Systematic Name English
5'-GMP
Common Name English
GUANYLIC ACID
Common Name English
INS-626
Code English
GUANOSINE 5'-PHOSPHORIC ACID
Common Name English
GUANIDINE MONOPHOSPHATE
Systematic Name English
GUANOSINE 5'-MONOPHOSPHATE
Systematic Name English
E-626
Code English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-626
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
JECFA EVALUATION INS-626
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
Code System Code Type Description
CAS
85-32-5
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
ECHA (EC/EINECS)
201-598-8
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
DRUG BANK
DB01972
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
CHEBI
58115
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
WIKIPEDIA
Guanosine monophosphate
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
MERCK INDEX
m5875
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY Merck Index
PUBCHEM
135398631
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
FDA UNII
16597955EP
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
EVMPD
SUB14039MIG
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
SMS_ID
100000077899
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
CHEBI
17345
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID9044295
Created by admin on Mon Mar 31 21:12:27 GMT 2025 , Edited by admin on Mon Mar 31 21:12:27 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT